(5751701), Q. D., (22654733), R. J., (12799), M. L., (128233), P. Z., (45632), F. L., (58638), Q. Z., . . . (462133), Y. W. (2025). Efficacy and safety of Ivarmacitinib in moderate-to-severe atopic dermatitis patients with or without previous systemic treatments: A post-hoc analysis of a phase III trial.
Citación estilo Chicago(5751701), Qingchun Diao, et al. Efficacy and Safety of Ivarmacitinib in Moderate-to-severe Atopic Dermatitis Patients with or Without Previous Systemic Treatments: A Post-hoc Analysis of a Phase III Trial. 2025.
Cita MLA(5751701), Qingchun Diao, et al. Efficacy and Safety of Ivarmacitinib in Moderate-to-severe Atopic Dermatitis Patients with or Without Previous Systemic Treatments: A Post-hoc Analysis of a Phase III Trial. 2025.